Company intelligence / Profile preview

Jolly Capital

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Jolly Capital is a Shanghai-based venture capital firm that specializes in the healthcare, life sciences, and advanced technology sectors. Founded in 2013, the firm primarily focuses on early and growth-stage investments in innovative drug development, high-end medical devices, and biotechnology within the Chinese market. Jolly Capital supports its portfolio companies through strategic guidance and capital injection, leveraging its deep network in the regional healthcare ecosystem. The firm has a track record of backing prominent Chinese enterprises in fields such as oncology, metabolic diseases, and diagnostics.

Industry: Investors

Beyond the preview

Go deeper on Jolly Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jolly Capital.

Explore the full profile